Filing Details
- Accession Number:
- 0001127602-25-007006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-26 20:24:21
- Reporting Period:
- 2025-02-24
- Filing Date:
- 2025-02-26
- Accepted Time:
- 2025-02-26 20:24:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1835597 | Pepgen Inc. | PEPG | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1553878 | Beth Mary Delena | C/O Pepgen Inc. 321 Harrison Ave, 8Th Floor Boston MA 02118 | General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-24 | 3,000 | $0.00 | 3,000 | No | 4 | A | Direct | |
Common Stock | Disposition | 2025-02-26 | 1,432 | $1.68 | 1,568 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- On February 6, 2024, the Reporting Person was granted performance-based stock units ("PSUs") under the 2022 Stock Option and Incentive Plan. Each PSU represents the right to receive one share of Common Stock upon vesting. The shares reported were issued to the Reporting Person upon achievement of a performance condition on February 24, 2025, as determined by the Compensation Committee of the Company's Board of Directors.
- Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units awarded to the Reporting Person on February 24, 2025. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.